|Articles|June 7, 2016
CMU Research Validates Improved Clinical Trial Processes
ICON plc announces the results of research evaluating patient-centric and patient-designed informed consent formats from Carnegie Mellon University.
Advertisement
ICON plc announces the results of research evaluating patient-centric and patient-designed informed consent formats from Carnegie Mellon University. The results show that patient consent forms could be shortened without losing understanding or required content.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
